[ad_1]
“I do not think” that it is necessary to wait until 2022 to have a vaccine available for the entire Italian population because “a prototype will be validated at the end of this year” and for production we are looking at “large production areas, not only located in Europe” , like India to which “a series of industrial proposals have already been advanced”. This was stated by Ranieri Guerra, deputy director general of the World Health Organization (WHO) and member of the Scientific Technical Committee (CTS), speaking on the Agorà broadcast on Rai Tre.
The president of the Irbm research center in Pomezia Piero Di Lorenzo, who collaborates with the University of Oxford for the creation of a vaccine against Covid 19 for Astra Zeneca, confirms the availability of the first doses for December, already announced in recent days by Prime Minister Giuseppe Conte. According to Di Lorenzo “if there are no sudden problems – he said during an interview with the Financial Lounge site – it is reasonable to think that the clinical trial phase may be complete by the end of November or beginning of December”. “After phase 3 – he continued – the balloon goes to EMA (the European Medicines Agency, ed) for possible validation”, which normally takes up to 12 months. “But these are not normal times,” explains Di Lorenzo, who remembers how the validation process has already begun.
“Sending messages saying we will have the vaccine in a month or two surely intercepts everyone’s expectations, but I see it quite unrealistic “. This was stated by Andrea Crisanti, Senior Lecturer in Microbiology at the University of Padua in Buongiorno, at Sky TG24. “Perhaps,” he explained, “in two months someone will say that we have a vaccine, but many months go by between saying it and doing a pilot study and then distributing it.”
REPRODUCTION RESERVED © Copyright ANSA
